Galmed Pharmaceuticals EOCN
NASDAQ EOCN
$3.12 +0.05 (+1.60%)
As of: Oct 21, 2026 · 3:44 PM EDT

Galmed Pharmaceuticals (EOCN) Interest Expenses (2022 - 2023)

Updated

Galmed Pharmaceuticals' Interest Expenses was -$4,000 in Q3 2025.

Analysis

Galmed Pharmaceuticals (EOCN) Interest Expenses (2022 - 2023) Analysis & Trends

For FY2024, Interest Expenses at Galmed Pharmaceuticals came in at $1,000, down 83.3% from FY2023.

  • Interest Expenses shows a five-year compound annual growth rate of -63.0% (FY2019 to FY2024).
  • In earlier years, Interest Expenses was $6,000 in FY2023, -$36,000 in FY2022, $6,000 in FY2021 (-96.0%) and $150,000 in FY2020 (+4.2%).
  • The Q3 2025 figure marks the highest quarterly Interest Expenses since Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 281.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 435.00 Mn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 247.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Galmed Pharmaceuticals 1.68 Mn -39.01 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 -172,000.00
Mar 31, 2022 51,000.00
API Access

Galmed Pharmaceuticals Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=EOCN&period=max&api_key=YOUR_API_KEY